MedTrace Logo

Evaluating the Effectiveness of Tion-Emo Therapy and Technique (TET)

NCT06950970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-04-30

No results posted yet for this study

Summary

The goal of this clinical trial is to explore the new therapy Cion-Emo therapy (TET) and to see if this technique is effective for treating depression and anxiety. Does TET lower anxiety and depression as participants learn and use this therapy? Researchers will compare TET with a control group to see if TET works in treating depression and anxiety. There was a pre-test and a post-test for both groups, experimental and control, and questionnaires to evaluate the effectiveness of TET. There was also a question to evaluate the hypothesis of the existence of nucleon emotion. The experimental group received TET therapy and techniques on an average of 10 to 12 one-hour sessions per week. The control group visited the clinic three times: in the first week all participants were evaluated to ascertain whether they were suffering from anxiety and depression; the second time was for the pre-test; and the third time was for the post-test.

Conditions

  • Depressive and Anxiety Disorders

Interventions

BEHAVIORAL

Tion-Emo therapy and technique for depression and anxiety Improvement

From 10 a 12 sessions once a week and one hour each session , for a positive result and development it is necessary to practice the technique

Sponsors & Collaborators

  • Rafael Navia

    lead OTHER

Principal Investigators

  • Rafael Navia · No afiliado

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-14
Primary Completion
2024-02-23
Completion
2025-02-08

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06950970 on ClinicalTrials.gov